These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7325278)

  • 21. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity.
    Dempsey WL; Mansfield JM
    J Immunol; 1983 Jan; 130(1):405-11. PubMed ID: 6847889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
    Hertz CJ; Mansfield JM
    Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune mechanisms in C57Bl mice genetically resistant to Trypanosoma congolense infection. I. Effects of immune modulation.
    Whitelaw DD; MacAskill JA; Holmes PH; Jennings FW; Urquhart GM
    Parasite Immunol; 1983 Jan; 5(1):85-94. PubMed ID: 6828326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma rhodesiense: variable effects of cyclophosphamide on antibody production, survival, and parasitemia in infected mice.
    Jones JF
    Exp Parasitol; 1986 Apr; 61(2):261-9. PubMed ID: 3956683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies.
    Sacks DL; Esser KM; Sher A
    J Exp Med; 1982 Apr; 155(4):1108-19. PubMed ID: 6977615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of resistance to the African trypanosomes. II. Differences in virulence associated with VSSA expression among clones of Trypanosoma rhodesiense.
    Inverso JA; Mansfield JM
    J Immunol; 1983 Jan; 130(1):412-7. PubMed ID: 6847890
    [No Abstract]   [Full Text] [Related]  

  • 27. Trypanosoma rhodesiense infection in mice: sex dependence of resistance.
    Greenblatt HC; Rosenstreich DL
    Infect Immun; 1984 Jan; 43(1):337-40. PubMed ID: 6690408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a new serodeme of Trypanosoma rhodesiense.
    Campbell GH; Esser KM; Wellde BT; Diggs CL
    Am J Trop Med Hyg; 1979 Nov; 28(6):974-83. PubMed ID: 92203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental infections with African trypanosomes. V. Preliminary parasitological, clinical, hematological, serological, and pathological observations in rhesus monkeys infected with Trypanosoma rhodesiense.
    Sadun EH; Johnson AJ; Nagle RB; Duxbury RE
    Am J Trop Med Hyg; 1973 May; 22(3):323-30. PubMed ID: 4196287
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction of human serum-sensitive Trypanosoma brucei stabilates into human serum-resistant "T. rhodesiense".
    Jennings FW; Urquhart GM
    Trans R Soc Trop Med Hyg; 1985; 79(1):80-5. PubMed ID: 3992646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of protective immunity in cattle by tsetse-transmitted cloned isolates of Trypanosoma congolense.
    Akol GW; Murray M
    Ann Trop Med Parasitol; 1985 Dec; 79(6):617-27. PubMed ID: 3834843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topologic mapping of protective and nonprotective epitopes on the variant surface glycoprotein of the WRATat 1 clone of Trypanosoma brucei rhodesiense.
    Hall T; Esser K
    J Immunol; 1984 Apr; 132(4):2059-63. PubMed ID: 6199421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced resistance of highly susceptible Balb/c mice to infection with Trypanosoma congolense after infection and cure.
    Otesile EB; Tabel H
    J Parasitol; 1987 Oct; 73(5):947-53. PubMed ID: 3309242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to Trypanosoma brucei in mice following inoculation of NTG-treated trypanosomes.
    Johnson RP; Chi LW
    Am J Trop Med Hyg; 1981 Sep; 30(5):952-4. PubMed ID: 6116437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes.
    Harris TH; Mansfield JM; Paulnock DM
    Infect Immun; 2007 May; 75(5):2366-73. PubMed ID: 17339353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of parasite antigen-specific lymphoid blastogenesis in African trypanosomiasis.
    Charoenvit Y; Campbell GH; Tokuda S
    J Immunol; 1981 Dec; 127(6):2350-4. PubMed ID: 6170700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater than one year protection of mice from lethal Trypanosoma rhodesiense infections by prophylactic drugs and active immunity.
    Kinnamon KE; Rane DS
    Int J Parasitol; 1978 Dec; 8(6):515-23. PubMed ID: 748222
    [No Abstract]   [Full Text] [Related]  

  • 38. Variable antigen type (VAT) composition of Trypanosoma brucei rhodesiense: discrepancy between results obtained using VAT-specific monoclonal antibodies and rabbit antisera.
    Burgess DE; Esser KM; Wellde BT
    Am J Trop Med Hyg; 1984 Nov; 33(6):1096-104. PubMed ID: 6391220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymerase chain reaction identification of
    Musaya J; Chisi J; Senga E; Nambala P; Maganga E; Matovu E; Enyaru J
    Malawi Med J; 2017 Mar; 29(1):5-9. PubMed ID: 28567189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular dialogue between African trypanosomes and humans].
    Pays E
    Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.